Abstract

The importance of the renin-angiotensin system for liver glucose output and flow was tested in 8 male subjects (age:25 +/- 1 yrs (mean and SE), Vo2max:4.0+/- 0.2 l/min). They performed semisupine cycling for 40 min at 50% Vo2max and 30 min at 70%Vo2max without (C) or with i.v. administration of an angiotensin-converting-enzyme inhibitor (10mg enalapril) (ACE) prior to exercise. Whole body glucose turnover was measured by primed constant infusion of 3H-glucose, and splanchnic substrate exchange and flow was measured by constant ICG-infusion and blood sampling from arterial and hepatic venous catheters. During exercise heart rate, mean arterial blood pressure, arterial lactate and RER increased similarly in drug and control studies (p>0.05). Hepatic glucose production increased during exercise similar in both experimental situations measured with 3H-glucose isotope dilution as well as with arterial and hepatic vein measurements (2.11 +/- 0.23 mg/min/kg to 7.29+/- 1.03 (ACE) and 2.21 +/- 0.18 to 7.82 +/- 0.70 (C)). Glucose production matched peripheral glucose uptake, and in both ACE and C arterial glucose did not change significantly during exercise (5.27 +/- 0.10 mM to 4.71 +/- 0.28(ACE) and 5.22 +/- 0.11 to 4.69 +/- 0.23 (C)). Splanchnic blood flow fell by 10% during moderate and 45% during intense exercise in both ACE (1.64 +/- 0.22 l/min to 1.52 +/- 0.20 (35 min) and 0.92 +/- 0.12 (65min)) and C (1.55 +/- 0.20 to 1.36 +/- 0.18 and 0.81 +/- 0.13) experiments. In conclusion Inhibition of the renin-angiotensin system does not influence neither the rise in hepatic glucose production nor the reduction in splanchnic flow during moderate or intense dynamic exercise in humans.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call